Timmy's Report  

   Timmy (not his real name) was a four year old boy who became part of an FDA approved clinical trial of oral dmps several years ago.  In that study, dmps was being investigated for its effectiveness in lead poisoning.  Timmy rapidly developed Stephens-Johnson syndrome".... a very serious skin condition.... shortly after receiving oral dmps." Therapy was immediately discontinued, and Timmy recovered in about ten days.  The researcher told me that he strongly suspects that the dmps caused the skin condition, but because Timmy had a pre-existing viral infection, he could not be absolutely sure.  In any event, because of this patient's serious reaction, and because it appeared that dmps was not very effective in lead poisoning cases, the researcher halted the study.

See Chisholm, J.J. Jr., "BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children." J Toxicol Clin Toxicol, 1992, 30:4, 493-504.




Last Updated: Monday, May 14, 2001 12:06 AM is optimized for Microsoft Internet Explorer in 800x600 resolution Please read our privacy, terms, and conditions agreement
Site Design By: Ryan H. Smith